These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28028298)

  • 1. MicroRNA expression in antiphospholipid syndrome: a systematic review and microRNA target genes analysis.
    Muhammad Shazwan S; Muhammad Aliff M; Asral Wirda AA; Hayati AR; Maizatul Azma M; Nur Syahrina AR; Nazefah AH; Jameela S; Nur Fariha MM
    Malays J Pathol; 2016 Dec; 38(3):273-283. PubMed ID: 28028298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches.
    Lopez-Pedrera C; Barbarroja N; Patiño-Trives AM; Collantes E; Aguirre MA; Perez-Sanchez C
    Front Immunol; 2019; 10():764. PubMed ID: 31040845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-19b-3p and miR-20a-5p are associated with the levels of antiphospholipid antibodies in patients with antiphospholipid syndrome.
    Juárez-Vicuña Y; Guzmán-Martín CA; Martínez-Martínez LA; Hernández-Díazcouder A; Huesca-Gómez C; Gamboa R; Amezcua-Guerra LM; Chacon-Perez M; Amigo MC; Sánchez-Muñoz F
    Rheumatol Int; 2021 Jul; 41(7):1329-1335. PubMed ID: 33891159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
    Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
    Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombotic mechanisms based on the impairment of fibrinolysis in the antiphospholipid syndrome.
    Forastiero R; Martinuzzo M
    Lupus; 2008 Oct; 17(10):872-7. PubMed ID: 18827051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of antiphospholipid score and anti-β2-glycoprotein I Domain I autoantibodies in the diagnosis of antiphospholipid syndrome.
    Mondejar R; González-Rodríguez C; Toyos-Sáenz de Miera FJ; Melguizo-Madrid E; Zohoury N; Mahler M; Romero Losquiño I; Fabiani F
    Clin Chim Acta; 2014 Apr; 431():174-8. PubMed ID: 24522162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiphospholipid antibody-induced miR-146a-3p drives trophoblast interleukin-8 secretion through activation of Toll-like receptor 8.
    Gysler SM; Mulla MJ; Guerra M; Brosens JJ; Salmon JE; Chamley LW; Abrahams VM
    Mol Hum Reprod; 2016 Jul; 22(7):465-74. PubMed ID: 27029214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic risk factors in thrombotic primary antiphospholipid syndrome: A systematic review with bioinformatic analyses.
    Islam MA; Khandker SS; Alam F; Kamal MA; Gan SH
    Autoimmun Rev; 2018 Mar; 17(3):226-243. PubMed ID: 29355608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid syndrome, "the best prophet of the future".
    Amengual O; Atsumi T
    Mod Rheumatol; 2018 May; 28(3):409-416. PubMed ID: 29385876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulins and antiphospholipid syndrome: How, when and why? A review of the literature.
    Tenti S; Cheleschi S; Guidelli GM; Galeazzi M; Fioravanti A
    Autoimmun Rev; 2016 Mar; 15(3):226-35. PubMed ID: 26656906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression in obstetric antiphospholipid syndrome: a systematic review.
    Muhammad Aliff M; Muhammad Shazwan S; Nur Fariha MM; Hayati AR; Nur Syahrina AR; Maizatul Azma M; Nazefah AH; Jameela S; Asral Wirda AA
    Malays J Pathol; 2016 Dec; 38(3):285-294. PubMed ID: 28028299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to Phosphatidylserine/Prothrombin Complex in Antiphospholipid Syndrome: Analytical and Clinical Perspectives.
    Peterson LK; Willis R; Harris EN; Branch WD; Tebo AE
    Adv Clin Chem; 2016; 73():1-28. PubMed ID: 26975968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J; Cabral AR; Alarcón-Segovia D
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antiphospholipid syndrome: still an enigma.
    Chaturvedi S; McCrae KR
    Hematology Am Soc Hematol Educ Program; 2015; 2015():53-60. PubMed ID: 26637701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical manifestations of antiphospholipid syndrome (APS) with and without antiphospholipid antibodies (the so-called 'seronegative APS').
    Rodriguez-Garcia JL; Bertolaccini ML; Cuadrado MJ; Sanna G; Ateka-Barrutia O; Khamashta MA
    Ann Rheum Dis; 2012 Feb; 71(2):242-4. PubMed ID: 21953349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of antiphospholipid syndrome.
    Horita T; Merrill JT
    Curr Rheumatol Rep; 2004 Dec; 6(6):458-62. PubMed ID: 15527705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance and correlations between anti-β2 glycoprotein I IgA assays in antiphospholipid syndrome and/or systemic lupus erythematosus.
    Tebo AE; Willis R; Jaskowski TD; Guerra M; Pierangeli SS; Salmon J; Petri M; Branch DW
    Clin Chim Acta; 2016 Sep; 460():107-13. PubMed ID: 27346478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antiphospholipid syndrome: from pathophysiology to treatment.
    Negrini S; Pappalardo F; Murdaca G; Indiveri F; Puppo F
    Clin Exp Med; 2017 Aug; 17(3):257-267. PubMed ID: 27334977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.